Literature DB >> 5309493

The results of controlled observations on the prophylaxis of influenza with interferon.

V D Solov'ev.   

Abstract

The results are reported of experimental investigations and epidemiological observations on the use of human leucocyte-produced interferon for influenza prophylaxis. Field trials with interferon were carried out during the outbreak of Hong Kong influenza in the USSR in January and February 1969. These covered about 14 000 people in comparable interferon-and placebo-treated groups and achieved an effectiveness of between 56.3% and 69.2% according to the age-group studied.The importance is shown, not only of artifically introduced interferon, but also of the interferon naturally produced by a subject in response to infection. The degree of such production varies both with each individual's capacity to form interferon and with the capacity of a particular strain of Hong Kong virus to elicit the productive response. The author suggests that isolated virus strains be subdivided into interferon-positive (I+) and interferon-negative (I-) strains according to the presence or absence of this phenotypic character.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5309493      PMCID: PMC2427762     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  Production of interferon by suspensions of human leucocytes.

Authors:  I GRESSER
Journal:  Proc Soc Exp Biol Med       Date:  1961-12

2.  [Sensitivity of various virus--cell systems to preparations of human interferon].

Authors:  T A Bektemirov; R I Rapoport
Journal:  Vopr Virusol       Date:  1967 Sep-Oct

3.  Combined inhibition of influenza virus reproduction in cell culture using interferon and amantadine.

Authors:  S V Lavrov; E I Eremkina; T G Orlova; G A Galegov; V D Soloviev; V M Zhdanov
Journal:  Nature       Date:  1968-03-02       Impact factor: 49.962

  3 in total
  21 in total

Review 1.  Antiviral agents: action and clinical use.

Authors:  T W Chang; D R Snydman
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

Review 2.  Interferons: anti-neoplastic drugs?

Authors:  H Strander
Journal:  Blut       Date:  1977-09-18

3.  Oral immunization against influenza virus.

Authors:  A Boudreault; V Pavilanis
Journal:  Arch Gesamte Virusforsch       Date:  1972

Review 4.  Interferon: therapeutic fact or fiction for the '80s?

Authors:  G M Scott; D A Tyrrell
Journal:  Br Med J       Date:  1980-06-28

Review 5.  Antiviral agents: an update--Part 2.

Authors:  S Bogger-Goren; P L Ogra
Journal:  Indian J Pediatr       Date:  1980 Nov-Dec       Impact factor: 1.967

Review 6.  Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.

Authors:  R B Pollard
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

7.  Combined interferon-alpha 2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro.

Authors:  F G Hayden; A N Schlepushkin; N L Pushkarskaya
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

8.  Estimates of the transmissibility of the 1968 (Hong Kong) influenza pandemic: evidence of increased transmissibility between successive waves.

Authors:  Charlotte Jackson; Emilia Vynnycky; Punam Mangtani
Journal:  Am J Epidemiol       Date:  2009-12-10       Impact factor: 4.897

Review 9.  Antiviral therapy. Respiratory infections, genital herpes, and herpetic keratitis.

Authors:  K G Nicholson
Journal:  Lancet       Date:  1984-09-15       Impact factor: 79.321

10.  Interferon aerosol suppression of vesicular stomatitis virus replication in the lungs of infected mice.

Authors:  P R Wyde; S Z Wilson; C S Sun; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.